Precision fermentation uses recombinant protein expression in an engineered microbe to secrete one defined ingredient, which is then separated from the biomass and purified. This article covers whey (beta-lactoglobulin), casein and dairy-type fats for food product development teams in the UAE and GCC.
Dairy supplies these components from milk; plant-based alternatives use plant proteins and oils. In precision fermentation, a bovine gene is placed in a yeast, fungus or bacterium. For GRN 001200, the notifier states that a synthesised, codon-optimised bovine beta-lactoglobulin gene was integrated into the genome of Komagataella phaffii[3]. These ingredients are often described as animal-free dairy proteins.
The protein can match the bovine sequence while the host, gene source and feedstock differ. GRN 001200 reports no antibiotic-resistance markers in the production strain[3]. In the EU, the production microbe also decides whether a product falls under novel food or GM food rules[4][5]. So, what do halal reviewers ask?
Four working questions organise a halal review: is the substrate permitted, are the host and gene source acceptable, do processing aids trace to permitted sources, and is the final composition free of non-halal components? They draw on three sources. Codex defines halal food as food that contains nothing unlawful under Islamic law, is not prepared, processed, transported or stored with equipment that is not free from anything unlawful, and has not been in direct contact with food that fails those conditions[1]. Saudi Arabia requires novel foods to be halal and to come from halal sources[6]. A 2025 commentary proposes review of feedstocks, genetic sequences and growth media[2]. No certifier checklist written for these ingredients was found.
Document the microbial host strain, its GMO status and the gene-sequence source. Records differ: GRN 001200 describes a synthesised gene[3], while SFA’s approval record for Remilk’s beta-lactoglobulin describes the native sequence of bovine beta-lactoglobulin variant B in K. phaffii yRMK-66[7]. List every component of the host organism and growth media, flagging animal-derived components and alcohol carriers; SFA’s record describes growth media of minerals and a carbon source[7]. This list anchors the substrate question.
Downstream purification removes the host. GRN 001200 lists centrifugation, filtration, ultrafiltration and cation-exchange chromatography, and discusses residual K. phaffii proteins[3]. Ask suppliers for residual host cell protein and recombinant DNA carryover data, processing aid traceability and cross-contact controls. Codex’s contact condition makes shared lines a halal question[1].
A bioidentical whey protein is animal-identical but not animal-derived. FDA states that GRN 001200 beta-lactoglobulin requires labelling because it contains protein derived from milk, so beta-lactoglobulin allergen labelling applies in the US[3]. Halal status and allergen status are separate questions. Figure 1 sets out the four questions as a working frame; a “no” at any node sends the file to the certifier, so the four answers should be on file before submission.
GCC practice rests on general halal and novel food frameworks; none found addresses precision fermentation halal status directly.
GSO 2055-1:2015, Halal Products – Part 1: General Requirements, approved on 5 November 2015, covers every stage of the halal food chain[8]. Dubai Municipality states that its laboratories are accredited to issue halal certificates for products, services and food, citing GSO 2055-2:2015 and UAE.S 2055-2:2016, the requirements for halal certification bodies[9]. In Saudi Arabia, SFDA.FD 513/2020, General Requirements of Novel Foods, requires novel foods to be halal, to come from halal sources and to meet GSO 2055-1[6]. The same regulation does not apply to food ingredients covered by GSO 2142/2011, General Requirements for Genetically Modified Foods and Feed[6], and it does not say whether a purified protein made by a genetically modified microbe falls under the novel food rule or the GM food standard. Codex CAC/GL 24-1997 gives the general definition and notes that the guidelines are subject to interpretation by the authorities of importing countries[1].
The GSO halal standard is sold per copy, so its clause-level treatment of recombinant ingredients was not verified. No MoIAT guidance on these ingredients was identified as of 20 October 2026 (searched: MoIAT halal and standards pages). The UAE’s novel food standard and registration route are covered in Part 2.
MUIS’s 2024 fatwa on cultivated meat holds that it can be halal if the cell source is a halal animal, all ingredients are halal and the product is safe and clean[10]. It does not address precision fermentation. No published guidance on microbially produced milk proteins was identified from MUIS, JAKIM or fiqh councils as of 20 October 2026 (searched: MUIS publications and web searches for JAKIM and fiqh council statements). Whether animal-free casein halal status can follow the cultivated-meat logic is unresolved. Where do the safety regulators stand?
FDA’s GRAS notice inventory records six precision-fermentation beta-lactoglobulin notices that closed with “FDA has no questions”: GRN 000863 (25 March 2020), 001056 (15 February 2023), 001145 (18 December 2023), 001200 (28 February 2025), 001241 (16 September 2025) and 001247 (19 September 2025)[11]. A “no questions” letter is not an affirmation that the substance is GRAS[12], and GRAS addresses safety, not halal status.
Casein is less advanced. FDA ceased evaluating GRN 001228 (beta-casein produced by Escherichia coli) at the notifier’s request on 13 June 2025, after FDA raised concerns about sodium, heavy metals and impurities[13]. Two further casein notices were listed as pending, with no FDA letter, when the inventory was checked on 20 October 2026[11]:
No GRAS notice for a fermentation-derived milk-fat analogue was identified in the inventory[11]. Next: Europe.
Precision-fermentation novel food files fall under Regulation (EU) 2015/2283, which excludes GM food covered by Regulation (EC) No 1829/2003[4]. EFSA’s novel food guidance, applying from 1 February 2025, places products of genetically modified microorganisms (GMMs) in categories 1 and 2 under the novel food regulation, and categories 3 and 4 outside it[5]. EFSA gives the safety opinion and the Commission authorises by implementing act[4] (see our EU novel food authorisation pathway).
Beta-lactoglobulin isolated from bovine whey received an EFSA opinion in 2022 and was authorised by Regulation (EU) 2022/2534[14][15]. That is a different source. For fermentation-derived beta-lactoglobulin, the Commission still publishes the summary of application 2023-19996 (Remilk Ltd., beta-lactoglobulin produced by K. phaffii)[16][17]. Its current status could not be confirmed from an official source, as the Commission page gives no status for individual applications. No EFSA opinion or Union list authorisation for fermentation-derived beta-lactoglobulin, casein or fats was identified as of 20 October 2026 (searched: Commission application summaries, EFSA Journal and EFSA guidance pages). Then Singapore.
SFA treats foods from fermentation as novel foods that must be approved before sale, and bars misrepresenting how they are made; milk proteins from fermentation must not be labelled as coming from cows[18]. SFA novel food approval is recorded in SFA’s public List of Approved Novel Foods (version as at 14 August 2026)[7].
Entry 7, “Animal free beta-lactoglobulin” (applicant Remilk), was approved on 20 February 2023. It is produced by K. phaffii yRMK-66, and its specification requires at least 80% beta-lactoglobulin as a share of protein[7]. None of the list’s 17 entries is a fermentation-derived casein or milk fat[7]. Now the cross-agency view.
The three agencies assess safety, not religious permissibility. The map covers beta-lactoglobulin, casein and fats only.
Table 1. FRL regulatory map for precision-fermented dairy ingredients (checked 20 October 2026)
Legend: FDA response = “no questions” letter (not approval) · Listed = approved by that regulator · Pending = notice or application not yet decided · Ceased = evaluation stopped · Unclear = status not confirmed by an official source
| Ingredient | FDA (GRAS notice) | EFSA / EU (novel food) | SFA (novel food) | GCC halal |
|---|---|---|---|---|
| PF whey (beta-lactoglobulin) | FDA response. Six notices closed with no questions: GRN 000863, 001056, 001145, 001200, 001241, 001247 (25 Mar 2020 to 19 Sep 2025)[11] | Unclear. Summary of application 2023-19996 still published[16]; status not officially confirmed; no EFSA opinion identified. Bovine-whey beta-lactoglobulin (different source) authorised, Reg. (EU) 2022/2534[15] | Listed. Entry 7, approved 20 Feb 2023[7] | No published ruling identified |
| PF casein | Ceased / pending. GRN 001228 ceased, 13 Jun 2025[13]; GRN 001312 and 001348 pending, no FDA response[11] | None identified | Not listed[7] | No published ruling identified |
| PF fats | No notice for a fermentation-derived milk-fat analogue identified[11] | None identified | Not listed[7] | No published ruling identified |
Takeaway: regulators have recorded safety reviews of fermentation-derived beta-lactoglobulin, but no EU authorisation, no casein clearance and no GCC halal ruling were identified.
SFA’s record fields give a usable template: production strain, genetic modification, growth media and inputs, manufacturing process and specifications[7]. Add supplier declarations, a process flow diagram, processing-aid sources and allergen statements. For halal-certified fermentation ingredients, one file assembled once can serve certifiers, agency submissions and product development teams.
Dependencies, not dates: a published certifier position on recombinant ingredients, clause-level guidance in the GSO or UAE halal standards, and a clear registration route. Saudi rules already require halal sources for novel foods[6]. Build the regulatory dossier to answer both the safety and the halal question. For function, validation and UAE market entry, read Part 2, Formulating with Precision-Fermented Whey, Casein and Fats: Function, Validation and UAE Market Entry (2026).
Safety reviews of fermentation-derived beta-lactoglobulin are public in the US and Singapore; in the EU, an application summary is published but its status is unconfirmed. Casein is thinner: one US notice ceased and two pending, with no FDA response yet. No halal ruling is public. Precision fermentation halal decisions therefore rest on host, media and processing-aid documentation, so assemble it before a certifier asks.
If you are sourcing or launching a precision-fermented whey, casein or fat ingredient for the UAE or wider GCC, FRL can build the file a halal certifier and a regulator will both ask for:
“Before accepting a batch, I want the host strain, gene source, growth media and processing aids in writing. With no halal guidance yet, I’d collect that file now and send it to a certifier.”
Dr. Shreya Iyer, PhD (Food Science), Director of New Product Development, Food Research Lab
Start with FRL’s regulatory and scientific research service, or talk to our regulatory team about a GCC regulatory assessment for your ingredient.
Ingredient and media specifications, supplier declarations, a process flow diagram, processing-aid sources and allergen statements. SFA’s record fields (production strain, genetic modification, growth media, manufacturing process and specifications) are a usable template[7].
No ruling has been published yet. A review would examine the host, gene source, media and processing aids. No GCC-specific ruling on microbially produced casein was found as of 20 October 2026, and no fermentation-derived casein has an FDA “no questions” letter: one notice ceased and two are pending[11][13].